{"prompt": "['REduCing Immunogenicity to PegloticasE (RECIPE)', 'Protocol #Version v12: 13Jan2020', 'In addition to gout flare prophylaxis all participants will receive infusion prophylaxis throughout the study (e.g.,', 'fexofenadine (60 mg PO) the night before and fexofenadine (60 mg PO) and acetaminophen (1000 mg) the morning of', 'the infusion; and hydrocortisone (200 mg IV) immediately prior to the infusion).', 'Visit 4 (1 week)', 'Participants will report 1 week following Visit 3 for a blood draw and check of their CBC.', 'Laboratory', 'CBC with diff', 'sUA', 'MMF adherence', 'Visit 5 (2 weeks)', 'Obtain and record vital signs, including pulse rate, sitting blood pressure, and body temperature', 'Targeted Physical Exam', 'Review / update medical history concomitant medications', 'Assess any AEs, and record', 'Gout Flare assessment', 'Assess compliance (via pill count) and dispense course of MMF (1000 mg/twice per day) or PBO, with', 'dosing instructions', 'Laboratory', 'CBC with diff', 'CMP', 'sUA', 'Pregnancy test for premenopausal women', 'MMF adherence', 'Gout Flare Prophylaxis', 'Administer pegloticase infusion, per site guidelines', 'IR Prophylaxis/ Assess for IRs', 'Visit 6 (3 weeks)', 'Participants will report 1 week following Visit 3 for a blood draw and check of their CBC.', 'Laboratory', 'CBC with diff', 'MMF adherence', 'Visit 7 (4 weeks)', 'Obtain and record vital signs, including pulse rate, blood pressure, and body temperature', 'Targeted Physical Exam and joint assessment', 'Review / update concomitant medications', 'Assess any AEs, and record', 'Gout Flare assessment', 'PROs (PROMIS-29 & GIS instrument)', 'Assess compliance (via pill count) and dispense course of MMF (1000 mg/twice per day) or PBO, with', 'dosing instructions', 'Laboratory Assessments', '19']['REduCing Immunogenicity to PegloticasE (RECIPE)', 'Protocol #Version v12: 13Jan2020', 'CBC with diff', 'CMP', 'sUA', 'Pregnancy test for premenopausal', 'MMF adherence', 'Gout Flare Prophylaxis', 'IR Prophylaxis, / Assess for IRs', 'Administer pegloticase infusion, per site guidelines', 'Visit 8 (6 weeks)', 'Obtain and record vital signs, including pulse rate, blood pressure, and body temperature', 'Targeted Physical Exam and joint assessment', 'Review / update concomitant medications', 'Assess any AEs, and record', 'Gout Flare assessment', 'Assess compliance (via pill count) and dispense course of MMF (1000 mg/twice per day) or PBO, with', 'dosing instructions', 'Laboratory Assessments', 'CBC with diff', 'IgG', 'sUA', 'Pregnancy test for premenopausal women', 'CMP', 'MMF adherence', 'Pegloticase Antibody/Mechanistic Study', 'Gout Flare Prophylaxis', 'IR Prophylaxis / Assess for IRs', 'Administer pegloticase infusion, per site guidelines', 'Visit 9 (8 weeks)', 'Obtain and record vital signs, including pulse rate, blood pressure, and body temperature', 'Targeted Physical Exam and joint assessment', 'Review / update concomitant medications', 'Assess any AEs, and record', 'Gout Flare assessment', 'PROs (PROMIS-29 & GIS instrument)', 'Assess compliance (via pill count) and dispense course of MMF (1000 mg/twice per day) or PBO, with', 'dosing instructions', 'Laboratory Assessments', 'CBC with diff', 'CMP', 'sUA', 'Pregnancy test for premenopausal', 'MMF adherence', '20']['REduCing Immunogenicity to PegloticasE (RECIPE)', 'Protocol #Version v12: 13Jan2020', 'Gout Flare Prophylaxis', 'IR Prophylaxis/Assess for IRs', 'Administer pegloticase infusion, per site guidelines', 'Visit 10 (10 weeks)', 'Obtain and record vital signs, including pulse rate, blood pressure, and body temperature', 'Targeted physical exam', 'Review / update concomitant medications', 'Assess any AEs, and record', 'Gout Flare Assessment', 'Assess drug compliance (via pill count) and dispense course of MMF (1000 mg/twice per day) or PBO,', 'with dosing instructions', 'Laboratory Assessments', 'CBC with diff', 'CMP', 'sUA', 'Pregnancy test for premenopausal women', 'MMF adherence', 'Gout Flare Prophylaxis', 'IR Prophylaxis/Assess for IRs', 'Administer pegloticase infusion, per site guidelines', 'Visit 11 (12 weeks)', 'Obtain and record vital signs, including pulse rate, blood pressure, and body temperature', 'Review concomitant medications, and record', 'Assess any AEs, and record', 'Gout Flare Assessment', 'PROs (PROMIS-29 & GIS instrument)', 'Assess drug compliance (via pill count)', 'Physical Exam and detailed joint assessment', 'HEENT, and Neck', 'Cardiovascular', 'Respiratory', 'Gastrointestinal', 'Musculoskeletal', 'Neurologic', 'Integumentary', 'VS/Measurements', 'Laboratory Assessments', 'CBC with diff', 'IgG', 'sUA', 'Pregnancy test for premenopausal women', 'CMP', '21']\n\n###\n\n", "completion": "END"}